Literature DB >> 8663468

An activation function in Pit-1 required selectively for synergistic transcription.

W Chang1, W Zhou, L E Theill, J D Baxter, F Schaufele.   

Abstract

Synergistic transcription activation is a key component in the generation of the spectrum of eukaryotic promoter activities by a limited number of transcription factors. Various mechanisms could account for synergy, but a central question remains of whether synergism requires transcription factor functions that differ from those that direct independent activation. The rat growth hormone promoter is synergistically activated by the pituitary-specific transcription factor, Pit-1, and the thyroid hormone receptor (TR). Mutations that disrupted the previously described DNA binding and transcriptional activation domains of both Pit-1 and TR reduced Pit-1/TR synergy in parallel with their effects on the much weaker, independent Pit-1 and TR activations of the rat growth hormone promoter. Thus, Pit-1 and TR amplify each other's intrinsic activities. Mutations of Pit-1 that selectively inhibited synergism with the TR without affecting independent Pit-1 activity were also identified. Pit-1/TR synergy is therefore a consequence of a novel synergism-selective activity and synergism-independent Pit-1 and TR functions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663468     DOI: 10.1074/jbc.271.30.17733

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element.

Authors:  V Budhram-Mahadeo; M Parker; D S Latchman
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

2.  A Pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit Ras and estrogen stimulation of the prolactin gene promoter.

Authors:  Annie Jean; Arthur Gutierrez-Hartmann; Dawn L Duval
Journal:  Mol Endocrinol       Date:  2009-11-03

3.  Caspase-Mediated Cleavage of the Transcription Factor Sp3: Possible Relevance to Cancer and the Lytic Cycle of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Li-Yu Chen; Lee-Wen Chen; Chien-Hui Hung; Chun-Liang Lin; Shie-Shan Wang; Pey-Jium Chang
Journal:  Microbiol Spectr       Date:  2022-01-12

4.  Isoform-Specific Reduction of the Basic Helix-Loop-Helix Transcription Factor TCF4 Levels in Huntington's Disease.

Authors:  Kaja Nurm; Mari Sepp; Carla Castany-Pladevall; Jordi Creus-Muncunill; Jürgen Tuvikene; Alex Sirp; Hanna Vihma; Derek J Blake; Esther Perez-Navarro; Tõnis Timmusk
Journal:  eNeuro       Date:  2021-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.